Can tirzepatide or semaglutide affect your period?
Possibly. The labels we checked for tirzepatide (US Zepbound, UK Mounjaro) and semaglutide (US and UK Wegovy) do not list period changes, but FDA safety reports flag clots and bleeding between periods, without proving cause. Tirzepatide may make the pill less reliable, so a late period can mean pregnancy. Bleeding after menopause always needs checking.
Are period changes a listed side effect of tirzepatide or semaglutide?
No, period changes are not a listed side effect in the US and UK tirzepatide and semaglutide labels we opened, though reports raise questions.1234
We checked the whole US Zepbound and Wegovy labels.12 We also checked the side-effect sections of the UK Mounjaro and Wegovy SmPCs (UK prescribing documents).34 None used the terms menstrual, amenorrhoea (no periods) or dysmenorrhoea (period pain), or listed uterine or vaginal bleeding.1234 We did not open the Ozempic or US Mounjaro labels.
A 2026 study in Obstetrics & Gynecology looked at FDA side-effect reports from female patients aged 12 to 55.5 Semaglutide had more reports than expected of heavy bleeding, clots, bleeding between periods and infrequent periods.5 Tirzepatide's signals were limited to bleeding between periods and clots.5 Neither medicine had a signal for absent periods, irregular periods or period pain.5
These reports cannot show how often changes happen.5 Obesity also affects periods, so the authors could not rule it out as a cause and call for prospective studies.5 The main trials did not systematically record period changes.5
Why might your periods change on these medicines?
Several things can change periods while you are on these medicines, including pregnancy, sudden weight loss, perimenopause and polycystic ovary syndrome (PCOS, now PMOS on NHS pages).6
The NHS also names stress and some hormonal contraception as common causes of late or missed periods.6 It links heavy periods to the time near menopause, fibroids, endometriosis and adenomyosis.7
A 2023 pooled analysis covered 11 trials in PCOS, with 840 people.8 It found better period regularity on GLP-1 medicines than on metformin or placebo.8 Those trials tested exenatide and liraglutide, not tirzepatide or semaglutide, and results varied widely.8
A 2026 Cureus review says weight loss and metabolic improvement can restore ovulation and lead to unexpected conception.9 The UK Mounjaro SmPC says tirzepatide should not be used in pregnancy.3 The UK Wegovy SmPC recommends contraception during semaglutide treatment, and the US Wegovy label says to stop at least 2 months before a planned pregnancy.42
Can tirzepatide or semaglutide affect the pill or other contraception?
Tirzepatide may make the pill less reliable after starting or raising the dose, while the semaglutide labels we opened carry no such warning.1234
The US Zepbound label says the medicine may reduce how well oral contraceptives work.1 It advises switching to a non-pill method or adding a barrier such as a condom.11011 That applies for 4 weeks after starting and after each dose increase.1
The UK Wegovy SmPC does not expect semaglutide to reduce the pill's effectiveness.4 The US Wegovy label lists no clinically significant interaction with ethinylestradiol and levonorgestrel, two hormones in some pills.2
British Menopause Society guidance, summarised by GPnotebook, says these medicines may reduce absorption of oral hormone replacement therapy (HRT).12 It says ongoing unscheduled bleeding should be assessed.12
Which period changes need checking?
Bleeding after menopause, very heavy bleeding and bleeding between periods all need checking, whether or not the medicine turns out to be the cause.147
The NHS says bleeding after menopause should be checked, even if it is small or happened once.14 It is not usually serious, but can be a sign of cancer.14
The NHS counts a period as heavy if you change a pad or tampon every 1 to 2 hours.7 Bleeding over 7 days or clots over about 2.5 cm also count.7 The NHS also flags 3 missed periods in a row, or newly irregular periods.6
What do people on tirzepatide or semaglutide report about their periods?
From public patient forums: 394 Reddit threads in r/Zepbound, r/mounjarouk, r/WegovyWeightLoss, r/Mounjaro, r/Semaglutide and r/Ozempic, posts from October 2025 to October 2026. Personal reports, not medical evidence.
What people describe
- Matches FDA reports Many describe heavier or longer periods, or more clots. The FDA-report study flagged heavy bleeding for semaglutide and clots for both medicines, and it cannot prove cause.5
- Partly matches FDA reports Many describe late, missed or skipped periods. The same study flagged infrequent periods for semaglutide only, and found no signal for absent periods on either medicine.5
- Matches trials of other GLP-1s Several, often with PCOS, say cycles became regular or long-absent periods returned. Pooled trials found better regularity, but they tested exenatide and liraglutide, not these two medicines.8
- Not studied Many say bleeding began, increased or returned while using hormonal contraception. We found no trial that measured this.
- Not studied Several say periods became lighter, or that early changes settled within a few cycles. We found no study of either.
Advice people share
- Matches the NHS Many urge getting heavy, long, frequent or unusual bleeding checked, without assuming the medicine is responsible. The NHS names several other causes of heavy periods.7
- Matches the US Zepbound label Several treat the pill as possibly less reliable and use a backup or non-pill method. The US Zepbound label advises this for tirzepatide, while the UK Wegovy SmPC does not expect reduced pill effectiveness with semaglutide.14
- Matches the NHS Several suggest a pregnancy test when a period is late or missed. The NHS says most tests work from the first day of a missed period.13
- Label says otherwise A few describe skipping or moving doses around their periods. The US Zepbound label sets once-weekly dosing.1 A missed dose is taken within 4 days, and only after that is it skipped.1
In your country
The bleeding advice on this page comes from UK, Australian and US health sources, tirzepatide's pill advice is worded differently in the US and UK, and we could not open every country's label.
Australia
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.
Label: We could not open Australia's Mounjaro Product Information, so this page relies on the US and UK labels. Australian Pharmacist reports that the Therapeutic Goods Administration recommends the same 4-week pill precaution.15
Emergency number: 000
Canada
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.
Label: We could not open Canada's product monographs, so this page relies on the US and UK labels.
Emergency number: 911
France
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).
Label: We could not open the EU product information for Mounjaro or Wegovy, so this page relies on the US and UK labels.
Emergency number: 15 or 112
Germany
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.
Label: We could not open the EU product information for Mounjaro or Wegovy, so this page relies on the US and UK labels.
Emergency number: 112
India
Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).
Label: We could not find or open an Indian label, so this page relies on the US and UK labels.
Emergency number: 112
Saudi Arabia
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.
Label: We could not find or open a Saudi label, so this page relies on the US and UK labels.
Emergency number: 997 or 911
United Arab Emirates
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.
Label: We could not find or open a UAE label, so this page relies on the US and UK labels.
Emergency number: 998 for an ambulance, or 999
United Kingdom
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.
Label: The UK Mounjaro SmPC says no pill dose change is needed at a normal BMI. For women with obesity or overweight, it advises a non-pill method or a barrier for 4 weeks after starting and after each dose increase.3 UK regulator guidance gives the 4-week barrier advice to anyone taking the pill with Mounjaro.10
Emergency number: 999
United States
Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).
Label: The US Zepbound label gives the 4-week pill advice to all patients using oral hormonal contraceptives.1
Emergency number: 911
Get urgent care right away, at an urgent care clinic or hospital emergency department, if you bleed through two or more pads or tampons each hour for 2 to 3 hours in a row,17 if bleeding is suddenly much heavier than usual, or if a heavy period comes with symptoms of anaemia such as dizziness or weakness.18 Contact your prescriber or a doctor right away if you bleed after menopause,14 or if you have persistent or severe stomach pain, sometimes spreading to your back, which the US Zepbound label links to acute pancreatitis.1
Read the full picture
Related questions
Sources
- US Zepbound (tirzepatide) prescribing information, updated Aug 28, 2026. DailyMed
- US Wegovy (semaglutide) prescribing information, updated Jun 18, 2026. DailyMed
- UK Mounjaro KwikPen (tirzepatide) SmPC, updated on emc Sep 8, 2026. electronic Medicines Compendium
- UK Wegovy FlexTouch (semaglutide) SmPC, updated on emc Sep 22, 2026. electronic Medicines Compendium
- Fitch J. Report on Etminan and Frey, Obstetrics & Gynecology, 2026, DOI 10.1097/AOG.0000000000006367. Contemporary OB/GYN, Jul 20, 2026. We read this report of the study, not the full paper. PubMed record
- NHS. Stopped or missed periods
- NHS. Heavy periods
- Zhou and colleagues. GLP-1 receptor agonists on pregnancy rate and menstrual cyclicity in polycystic ovary syndrome. BMC Endocrine Disorders, 2023
- Almaradweh S, Mousa E. GLP-1 receptor agonists and reproductive health: a narrative review. Cureus, 2026
- MHRA, UK. GLP-1 medicines for weight loss and diabetes: what you need to know, updated Feb 5, 2026
- Prescribing Advice for GPs. Summary of the Faculty of Sexual and Reproductive Healthcare statement on GLP-1 agonists, Feb 19, 2025. Secondary summary.
- GPnotebook. GLP-1s and hormone replacement therapy, summarising British Menopause Society guidance of April 2025. Secondary summary.
- NHS. Doing a pregnancy test
- NHS. Post-menopausal bleeding
- Wikramanayake M. Tirzepatide users on oral contraceptives face pregnancy risk. Australian Pharmacist, Aug 24, 2026. Secondary report.
- NHS. Ectopic pregnancy
- Cleveland Clinic. Menorrhagia (heavy menstrual bleeding)
- healthdirect, Australian Government. Heavy periods
Last checked Nov 9, 2026 · Next review due Nov 9, 2027 · Report an error
How this answer was made. Written by the GLP Guidebook team from the sources above, all checked on Nov 9, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write